Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.550
-0.010 (-0.64%)
Nov 21, 2024, 1:19 PM EST - Market open
Cardiol Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -36.14 | -28.13 | -30.93 | -31.64 | -20.64 | -13.68 | |
Depreciation & Amortization | 0.39 | 0.25 | 0.22 | 0.22 | 0.23 | 0.15 | |
Asset Writedown & Restructuring Costs | - | - | 1.36 | 0.08 | 0.08 | 0.5 | |
Stock-Based Compensation | 12.14 | 4.17 | 5.54 | 12.61 | 2.81 | 3.27 | |
Other Operating Activities | -1.95 | -0.93 | -9.15 | -4.89 | 0.07 | 0.01 | |
Change in Accounts Receivable | 0.12 | 0.07 | -0.14 | -0.06 | 0.01 | 0.02 | |
Change in Inventory | - | - | - | 0.02 | 5.85 | 0.14 | |
Change in Accounts Payable | -0.9 | -1.29 | 4.47 | 2.39 | 1.83 | -1.5 | |
Change in Other Net Operating Assets | 0.39 | 0.68 | 1.42 | -2.27 | 0.64 | -0.28 | |
Operating Cash Flow | -25.93 | -25.18 | -27.22 | -23.54 | -9.13 | -11.38 | |
Capital Expenditures | -0.03 | -0.06 | -0.07 | -0.01 | -0.04 | -0.42 | |
Investing Cash Flow | -0.03 | -0.06 | -0.07 | -0.01 | -0.04 | -0.42 | |
Long-Term Debt Repaid | - | -0.06 | -0.05 | -0.05 | -0.05 | -0.02 | |
Net Debt Issued (Repaid) | -0.04 | -0.06 | -0.05 | -0.05 | -0.05 | -0.02 | |
Issuance of Common Stock | 0.18 | - | - | 98.72 | 17.43 | 2.05 | |
Other Financing Activities | - | - | - | -5.23 | -1.09 | - | |
Financing Cash Flow | 0.14 | -0.06 | -0.05 | 93.44 | 16.3 | 2.03 | |
Foreign Exchange Rate Adjustments | 1.17 | 0.76 | 2.92 | -0.01 | -0.06 | - | |
Net Cash Flow | -24.66 | -24.54 | -24.43 | 69.87 | 7.07 | -9.78 | |
Free Cash Flow | -25.96 | -25.24 | -27.3 | -23.55 | -9.17 | -11.8 | |
Free Cash Flow Margin | - | - | - | -29904.22% | - | - | |
Free Cash Flow Per Share | -0.38 | -0.39 | -0.44 | -0.54 | -0.31 | -0.46 | |
Levered Free Cash Flow | -19.97 | -14.99 | -20.64 | -4.61 | -1.61 | -6.06 | |
Unlevered Free Cash Flow | -19.97 | -14.99 | -20.64 | -4.61 | -1.61 | -6.06 | |
Change in Net Working Capital | 0.57 | 0.73 | 0.49 | -6.74 | -8.32 | 1.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.